The Activated Macrophage Colony-Stimulating Factor (CSF-1) Receptor as a Predictor of Poor Outcome in Advanced Epithelial Ovarian Carcinoma
- 1 February 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 80 (2) , 194-200
- https://doi.org/10.1006/gyno.2000.6070
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibodyOncogene, 1997
- Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survivalAmerican Journal of Obstetrics and Gynecology, 1993
- Increased serum levels of macrophage colony-stimulating factor in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- CSF‐1—A mononuclear phagocyte lineage‐specific hemopoietic growth factorJournal of Cellular Biochemistry, 1983